96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
METHODS TO SPECIFICALLY PROFILE PROTEASE ACTIVITY AT LYMPH NODES
#602BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17
#603PEPTIDES THAT ENHANCE NMDA RECEPTOR FUNCTION AND USE THEREOF
#604COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES
#605Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#606Oligopeptide, Testing Kit Thereof And Medical Composition Thereof
#607Compositions and methods for cell delivery
#608METHOD OF CHARACTERIZING THE BINDING CHARACTERISTICS BETWEEN A PEPTIDE OF INTEREST AND MHC MOLECULES
#609BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR IL-17
#610Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#611PHOSPHORYLATED AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#612PIF BINDING AS A MARKER FOR IMMUNE DYSREGULATION
#613GhR-BINDING PEPTIDE AND COMPOSITION COMPRISING SAME
#614HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES
#615Derived peptide of lactoferrin and method thereof for promoting and/or increasing lipid synthesis
#616COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY
#617ENGINEERED CELLS AND USES THEREOF
#618Peptides and methods for the treatment of diabetes
#619SELF-ASSEMBLING CIRCULAR TANDEM REPEAT PROTEINS WITH INCREASED STABILITY
#620Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#621Antigen analogue for calibration of immunometric diagnostic assays
#622PEPTIDE-HINGE-FREE FLEXIBLE ANTIBODY-LIKE MOLECULE
#623Broad-spectrum anti-infective peptides
#624LAG3 binding peptides
#625Synthetic peptide SP2 and application thereof
#626Peptide for the delivery of anionic materials
#627Compositions and methods for transport across the blood brain barrier
#628Peptides and T cells for use in immunotherapeutic treatment of various cancers
#629Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#630COMPOSITIONS AND METHODS FOR INHIBITING NEOINTIMAL FORMATION
#631METAL-BINDING PEPTIDE, AND USE THEREOF
#632Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#633ANTIBODY SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#634PEPTIDE LIBRARY AND USE THEREOF
#635Stapled and stitched polypeptides and uses thereof
#636Compositions and method for optimized peptide vaccines using residue optimization
#637PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#638METHOD FOR PRODUCING MONOVALENT CCAP PRODUCT
#639Personalized immunotherapy against several neuronal and brain tumors
#640Personalized immunotherapy against several neuronal and brain tumors
#641METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
#642A SERIES OF INJECTABLE HYDROGELS SELF-ASSEMBLED FROM SHORT PEPTIDES FOR VARIOUS BIOMEDICAL APPLICATIONS
#643Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy
#644Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#645NOVEL TUMOR-SPECIFIC ANTIGENS FOR OVARIAN CANCER AND USES THEREOF
#646NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#647RARE EARTH ELEMENT (REE)-BINDING PROTEINS
#648COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#649Peptide targeting toxin-antitoxin system and use thereof
#650SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS
#651CD200 inhibitors and methods of use thereof
#652Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#653Synthetic peptide sp4 and use thereof
#654Peptides and T cells for use in immunotherapeutic treatment of various cancers
#655Anti-inflammatory peptides and composition comprising the same
#656ANTIGENIC NEURON SPECIFIC ENOLASE PEPTIDES FOR DIAGNOSING AND TREATING AUTISM
#657THERAPEUTIC PEPTIDES
#658THERAPEUTIC PEPTIDES
#659THERAPEUTIC PEPTIDES
#660Fill-finish process for peptide solutions
#661Peptides and T cells for use in immunotherapeutic treatment of various cancers
#662NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#663ENGINEERED YEAST FOR NONMAGNETIC FINES RECOVERY
#664LUNG-SPECIFIC TARGETING-PEPTIDE (LTP), COMPOSITIONS, AND USES THEREOF
#665COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#666PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES
#667Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#668COMPSTATIN ANALOGUES AND THEIR MEDICAL USES
#669THERAPEUTIC PEPTIDES
#670PEPTIDE INHIBITORS FOR THE INHIBITION OF HIV CAPSID
#671BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1
#672Cell penetrating peptides and uses thereof
#673POLYPEPTIDE AND APPLICATION THEREOF
#674Immunotherapy against several tumors including lung cancer
#675PEPTIDES HAVING INHIBITORY ACTIVITY ON NEURONAL EXOCYTOSIS
#676METHOD FOR DIAGNOSING AND TREATING ATHEROSCLEROSIS BY USING NANOVESICLE TARGETING SITE OF CHANGE IN BLOOD FLOW
#677NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#678SYNTHETIC ANTIMICROBIAL PEPTIDES
#679Bicyclic peptide ligands specific for EphA2
#680EPITOPES
#681PREDICTION DEVICE, TRAINED MODEL GENERATION DEVICE, PREDICTION METHOD, AND TRAINED MODEL GENERATION METHOD
#682CRM197 PROTEIN EXPRESSION METHOD
#683pH-SENSITIVE CYCLIC PEPTIDES
#684Immunotherapy against several tumors including lung cancer
#685POLYPEPTIDE AND USE THEREOF
#686COMPOSITIONS COMPRISING BOVINE ADRENAL MEDULLA 8-22 (BAM8-22) PEPTIDE ANALOGS AND METHODS OF USE
#687Peptides and combination of peptides for use in immunotherapy against various cancers
#688Peptides and combination of peptides for use in immunotherapy against various cancers
#689HIGH YIELD PRODUCTION AND USE OF ENZYMATIC-EXCHANGEABLE PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SINGLE CHAIN TRIMER TETRAMER
#690IL-2RBETA BINDING COMPOUNDS
#691COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#692NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#693Temporal traumatic brain injury biomarkers and methods of use thereof
#694ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
#695COMPOSITIONS COMPRISING CHEMERIN ANALOGS AND METHODS OF USE
#696P53 ACTIVATOR PEPTIDOMIMETIC MACROCYCLES
#697Peptides and combination of peptides for use in immunotherapy against various cancers
#698Peptides and combination of peptides for use in immunotherapy against various cancers
#699Peptides and combination of peptides for use in immunotherapy against various cancers
#700ACETYLCHOLINE MODULATION OF IMMUNE FUNCTION
#701PHARMACEUTICAL COMPOSITION CONTAINING COMPLEXES OF ALLOFERON AND ZINC
#702HUMAN APOB100 EPITOPES, METHODS AND USES FOR MODULATING INFLAMMATORY RESPONSES, AND TREATING ADVERSE CARDIOVASCULAR EVENTS, DISEASE AND ATHEROSCLEROSIS
#703Inhibitors and Use Thereof in Cancer Treatment
#704FILL-FINISH PROCESS FOR PEPTIDE SOLUTIONS
#705BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2
#706Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#707Peptides and combination of peptides for use in immunotherapy against various cancers
#708Peptides and combination of peptides for use in immunotherapy against various cancers
#709Anti HLA-G specific antibodies
#710DPEP-1 BINDING AGENTS AND METHODS OF USE
#711Peptides and combination of peptides for use in immunotherapy against various cancers
#712Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma
#713Peptides and T cells for use in immunotherapeutic treatment of various cancers
#714GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers
#715Dietary peptides
#716NOVEL INTERMEDIATE USED FOR BIOLOGICALLY ACTIVE POLYPEPTIDE AND METHOD FOR PREPARING SAME
#717Therapeutic peptides
#718Heterotandem bicyclic peptide complex
#719AGONIST OF SPEXIN-BASED GALANIN TYPE 2 RECEPTOR AND USE THEREOF
#720Neuronal nicotinic acetylcholine receptor-targeting polypeptide and use thereof
#721Novel Selective ACKR3 Modulators and Uses Thereof
#722Epitope-Based Approach for Allergy Treatments and Inhibitors for Crohn's Disease
#723PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#724PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#725Treatments for Gastrointestinal Disorders
#726HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES
#727Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
#728Methods for efficient delivery of therapeutic molecules in vitro and in vivo
#729THERAPEUTIC PEPTIDES
#730Method for treating non-small lung cancer with a population of activated cells
#731Peptides and T cells for use in immunotherapeutic treatment of various cancers
#732NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS
#733PPR PROTEIN CAUSING LESS AGGREGATION AND USE OF THE SAME
#734VASCULAR CHOLESTEROL INHIBITORS AND USE THEREOF
#735Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
#736Peptide for treating sepsis derived from Rv2626c protein of
#737Methods for Detecting A Mycobacterium Tuberculosis Infection
#738AAV9 affinity agents
#739Agents modulating beta-catenin functions and methods thereof
#740STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN
#741HALOGENATED ANTIMICROBIAL PEPTOIDS
#742PEPTIDE EXHIBITING EXCELLENT ADHESION TO RESINS AND BIOCOMPATIBLE FUNCTIONAL MATERIAL USING SAME
#743Polypeptide EXP and its drug delivery system as well as extracellular vesicle extraction
#744PEPTIDE ANTIBIOTICS AND METHODS OF USE THEREOF
#745Compositions and methods of inhibiting the binding of plasma IGG autoantibodies to serotonin 2A receptor
#746DELIVERY PEPTIDES AND METHODS OF USING THE SAME
#747Peptide, compositions and method for delivery of agents into cells and tissues
#748PEPTIDE-BASED NON-PROTEINACEOUS CARGO DELIVERY
#749Immunotherapy against several tumors including lung cancer
#750PEPTIDE LIGANDS FOR BINDING TO PSMA
#751PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS
#752Tissue occluding agent comprising an ieikieikieiki peptide
#753PEPTIDE-DERIVED THERAPEUTICS TARGETING KDM5C FOR THE TREATMENT OF CANCER
#754HER3 peptides for imaging and radiotherapy
#755PEPTIDES DERIVED FROM TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER 1 (TRPM1), COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
#756Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Glioblastoma
#757Peptides and T cells for use in immunotherapeutic treatment of various cancers
#758Chloride salt of TAT-NR2B9C
#759METHODS AND COMPOSITIONS COMPRISING A C-TERMINAL BAX PEPTIDE
#760VASCULAR EMBOLIC SYSTEM
#761Leech polypeptide and use thereof
#762NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
#763PEPTIDE COMPLEX AND PRODUCTION METHOD THEREFOR, AND USE OF SAID PEPTIDE COMPLEX
#764Peptides and T cells for use in immunotherapeutic treatment of various cancers
#765Di-sulfide containing cell penetrating peptides and methods of making and using thereof
#766Peptides, Reagents And Methods For Detecting Food Allergy
#767Integrin antagonists
#768PEPTIDES FOR PREVENTING BIOFILM FORMATION
#769Carrier peptide fragment and use thereof
#770Cancer Antigen Peptide
#771Cancer Antigen Peptide
#772Cancer Antigen Peptide
#773Method for detection and quantification of CLN3 protein
#774Methods for detecting peptide/MHC/TCR binding
#775Insulin like growth factor binding protein bioactive peptide fragments
#776DE NOVO DESIGN OF TUNABLE PH-DRIVEN CONFORMATIONAL SWITCHES
#777Antiplasmodial compounds
#778NANOMOLAR PEPTIDES AND DERIVATIVES TO DIFFERENTIALLY MODULATE EPHRIN RECEPTORS
#779POLYPEPTIDE HAVING ANTIBACTERIAL ACTIVITY, COMPOSITION FOR PREVENTING OR TREATING SEPSIS COMPRISING SAME, AND ANTIBACTERIAL COMPOSITION
#780Peptides having inhibitory activity on muscarinic receptor M3
#781Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#782Soluble lipidated ligand agents for treating eye inflammation
#783ANTIBACTERIAL PEPTIDES AND METHODS OF USE
#784SYNTHESIS OF BICYCLE TOXIN CONJUGATES, AND INTERMEDIATES THEREOF
#785Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#786PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#787MELANOCORTIN RECEPTOR LIGANDS
#788COMPOSITIONS AND METHODS FOR INDUCING ANTIGEN-SPECIFIC TOLERANCE
#789ANTI-MICROBIAL PEPTIDES AND METHOD FOR DESIGNING NOVEL ANTI-MICROBIAL PEPTIDES
#790Compositions for preventing or treating viral and other microbial infections
#791BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR INTEGRIN ALPHA-V-BETA-3
#792Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#793DUAL IL-2R AND IL-7R BINDING COMPOUNDS
#794IL-2alpha receptor subunit binding compounds
#795Treatments for Gastrointestinal Disorders
#796Polypeptides and compositions comprising the same
#797BI-SPECIFIC EXTRACELLULAR MATRIX BINDING PEPTIDES AND METHODS OF USE THEREOF
#798ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME
#799ARTIFICIAL RECOMBINANT PROTEIN FOR IMPROVING PERFORMANCE OF ACTIVE PROTEIN OR POLYPEPTIDE AND USE THEREOF
#800PEPTIDE AND FOR TREATING INFLAMMATORY DISEASE AND PAIN USING THE SAME
#801Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicine
#802Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#803Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#804IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF
#805Immunomodulatory peptides
#806Branched peptides for enzymatic assembly and mitochondria drug delivery
#807Neuroprotective peptides
#808Methods of treatment comprising Selenoprotein P fragment-containing compounds
#809NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS
#810PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS
#811CYCLIC PEPTIDE, CELL SCAFFOLD MATERIAL, CELL SEPARATING MATERIAL, AND MEDIUM
#812Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#813Transfection complexes and methods of using the same
#814MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#815ANTIMICROBIAL PEPTIDES
#816MODIFIED PEPTIDES
#817Pharmaceutical composition and the use thereof in the treatment of autoimmune diseases
#818C1q and HMGB1 fusion proteins and uses thereof
#819Bicyclic peptide ligands specific for Nectin-4
#820Fc Receptor-ACE2 Conjugates and Use Thereof
#821Carrier Peptide Fragment and Use Thereof
#822DITHIOCARBAMATE STAPLED PEPTIDES AND METHODS OF MAKING AND USE THEREOF
#823ANTIMICROBIAL PEPTIDES
#824CARRIER PROTEIN FOR IMPROVING PROPERTIES OF BIOACTIVE PROTEIN
#825Peptide oligonucleotide conjugates
#826PEPTIDES AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#827THERAPEUTIC NANOCONJUGATES AND USES THEREOF
#828REACTIVE PEPTIDE LABELING
#829Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto
#830Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#831Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#832Immunotherapy against several tumors including lung cancer
#833Antimicrobial And Antibiofilm Peptides Sequences With Metal-Binding Motifs
#834BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR CD38
#835DEFENSIN FRAGMENTS FOR USE IN THERAPY OR PROPHYLAXIS
#836PEPTIDES AND MEDICAL USES THEREOF
#837Anti HLA-G specific antibodies
#838Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
#839PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#840Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#841Anti-inflammatory nanofibers
#842ANTIBODY/DRUG CONJUGATES AND METHODS OF USE
#843Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods
#844Cleavable linker compositions and methods
#845CD40 TARGETED PEPTIDES AND USES THEREOF
#846EPITOPE TAGS RECOGNIZED BY SPECIFIC BINDERS
#847Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
#848PHOTOCROSSLINKING PEPTIDES FOR SITE SPECIFIC CONJUGATION TO FC-CONTAINING PROTEINS
#849ANTIMICROBIAL PEPTIDES AND COMPOSITIONS, METHODS, ARTICLES & KITS RELATING THERETO
#850Variable lymphocyte receptors that target the brain extracellular matrix and methods of use
#851PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES
#852Anti-erythropoietin receptor peptide
#853CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
#854Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist
#855SELF-ASSEMBLING PEPTIDE COMPOSITIONS
#856LAG3 binding peptides
#857Process for the preparation of plecanatide
#858PEPTIDE TARGETING MYCOBACTERIUM TUBERCULOSIS TOXIN-ANTITOXIN SYSTEM AND USE THEREOF
#859Anti-microbial peptides
#860Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of colorectal cancer
#861Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#862Hydrogel-forming peptides, and methods of use thereof
#863Bicyclic peptide ligands specific for MT1-MMP
#864Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#865Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#866EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
#867GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#868Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#869METHODS OF SELECTING FUNCTIONAL INTERFACE MIMICS, AND COMPOSITIONS THEREOF
#870ARTIFICIAL INTELLIGENCE DESIGNED ANTIMICROBIAL PEPTIDES
#871Polypeptide-based ocular absorption enhancer and application thereof
#872BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR FAPa
#873Bone-Targeting Therapeutic Compositions and Methods of Using Them
#874Fusion peptides as antimicrobial agents
#875PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES
#876Sterilization and filtration of peptide compositions
#877PEPTIDOMIMETIC MACROCYCLES
#878BI-FUNCTIONAL ARGININE-GLYCINE-ASPARTIC ACID (RGD) PEPTIDES AND METHODS TO PROMOTE ANGIOGENESIS
#879Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
#880Peptides, combination of peptides as targets and for use in immunotherapy
#881Ultra-pure agonists of guanylate cyclase C, method of making and using same
#882Dosing regimens and related compositions and methods
#883Material and method to screen proteasome stimulators
#884Peptide that regulates fat metabolism and method for regulating fat metabolism
#885POLYPEPTIDES FOR THE TREATMENT OF STRESS, IMMUNOREACTION AND STROKE SYNDROMES
#886PEPTIDE FOR COSMETIC APPLICATION
#887Personalized immunotherapy against several neuronal and brain tumors
#888Neurodegenerative disorders
#889Circular tandem repeat proteins
#890Treatments for Gastrointestinal Disorders
#891Pharmacokinetics and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and therapy
#892NEUTRAL MULTIDOMAIN PEPTIDE HYDROGELS AND USES THEREOF
#893PET-IMAGING IMMUNOMODULATORS
#894Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#895SARS-CoV-2 epitope-targeted peptide immunostimulants
#896Cationic peptides for activating Lck
#897Solid-phase carrier including IgG-binding peptide, and IgG separation method
#898Immunomodulatory compounds
#899INHIBITORY T CELL RECEPTOR PEPTIDES AND DISCOVERY METHODS
#900MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications